Y-39983, a selective Rho-kinase inhibitor, attenuates experimental autoimmune encephalomyelitis via inhibition of demyelination - PubMed (original) (raw)
doi: 10.1159/000353568. Epub 2013 Aug 30.
Affiliations
- PMID: 24008512
- DOI: 10.1159/000353568
Y-39983, a selective Rho-kinase inhibitor, attenuates experimental autoimmune encephalomyelitis via inhibition of demyelination
Cong Gao et al. Neuroimmunomodulation. 2013.
Abstract
Objective: Rho-associated kinase (ROCK) is a serine/threonine kinase and a major downstream effector of the small GTP-binding protein, Rho. Rho-ROCK triggers an intracellular signaling cascade that controls actin cytoskeleton and is essential for cell motility and adhesion, neurite outgrowth and retraction. In chronic disabling disease, multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE), demyelination and axonal damage are the major pathological changes contributing to neurological disability. We investigated the protective effect of a specific ROCK inhibitor, Y-39983, on demyelination and axonal damage in chronic EAE.
Methods: Western blotting for myelin proteins, electron microscopy and solochrome cyanine staining was performed to evaluate demyelination while neurofilament proteins and cytoskeletal proteins including β-actin and β-tubulin were used to determine axonal damage in a chronic mouse model of EAE treated with Y-39983.
Results: Y-39983 significantly suppressed clinical symptoms of EAE and prevented its relapse while increasing the amount of myelin proteins. No significant changes in neurofilaments and cytoskeletal proteins were observed compared with control EAE mice. The inhibition of demyelination by Y-39983 was confirmed by solochrome cyanine staining and electron microscopy. To further study the effect of Y-39983 on demyelination in EAE, we tested three major ROCK substrates, including myosin light chain phosphorylation, LIMK2 and collapsin response mediator protein-2. The activity of these molecules was decreased in EAE animals treated with Y-39983.
Conclusion: The inhibitory effect of Y-39983 on demyelination is probably due to the inactivation of ROCK substrates, which are important for neurite outgrowth, growth cone collapse and demyelination of oligodendrocytes.
Copyright © 2013 S. Karger AG, Basel.
Similar articles
- Protective effect of a novel Rho kinase inhibitor WAR-5 in experimental autoimmune encephalomyelitis by modulating inflammatory response and neurotrophic factors.
Li YH, Yu JZ, Xin YL, Feng L, Chai Z, Liu JC, Zhang HZ, Zhang GX, Xiao BG, Ma CG. Li YH, et al. Exp Mol Pathol. 2015 Oct;99(2):220-8. doi: 10.1016/j.yexmp.2015.06.016. Epub 2015 Jun 23. Exp Mol Pathol. 2015. PMID: 26112093 - Estrogen inhibits estrogen receptor α-mediated rho-kinase expression in experimental autoimmune encephalomyelitis rats.
Feng J, Zhang G, Hu X, Si Chen C, Qin X. Feng J, et al. Synapse. 2013 Jul;67(7):399-406. doi: 10.1002/syn.21650. Epub 2013 Mar 25. Synapse. 2013. PMID: 23401288 - Organized migration of epithelial cells requires control of adhesion and protrusion through Rho kinase effectors.
Hopkins AM, Pineda AA, Winfree LM, Brown GT, Laukoetter MG, Nusrat A. Hopkins AM, et al. Am J Physiol Gastrointest Liver Physiol. 2007 Mar;292(3):G806-17. doi: 10.1152/ajpgi.00333.2006. Epub 2006 Nov 30. Am J Physiol Gastrointest Liver Physiol. 2007. PMID: 17138966 - Therapeutic potentials of the Rho kinase inhibitor Fasudil in experimental autoimmune encephalomyelitis and the related mechanisms.
Yan Y, Yu J, Gao Y, Kumar G, Guo M, Zhao Y, Fang Q, Zhang H, Yu J, Jiang Y, Zhang HT, Ma CG. Yan Y, et al. Metab Brain Dis. 2019 Apr;34(2):377-384. doi: 10.1007/s11011-018-0355-7. Epub 2018 Dec 14. Metab Brain Dis. 2019. PMID: 30552558 Review. - Pathophysiological role of calpain in experimental demyelination.
Shields DC, Banik NL. Shields DC, et al. J Neurosci Res. 1999 Mar 1;55(5):533-41. doi: 10.1002/(SICI)1097-4547(19990301)55:5<533::AID-JNR1>3.0.CO;2-8. J Neurosci Res. 1999. PMID: 10082076 Review.
Cited by
- Evaluation of Rho kinase inhibitor effects on neuroprotection and neuroinflammation in an ex-vivo retinal explant model.
Reboussin É, Bastelica P, Benmessabih I, Cordovilla A, Delarasse C, Réaux-Le Goazigo A, Brignole-Baudouin F, Olmière C, Baudouin C, Buffault J, Mélik Parsadaniantz S. Reboussin É, et al. Acta Neuropathol Commun. 2024 Sep 14;12(1):150. doi: 10.1186/s40478-024-01859-z. Acta Neuropathol Commun. 2024. PMID: 39300576 Free PMC article. - Effects of Bu Shen Yi sui capsule on NogoA/NgR and its signaling pathways RhoA/ROCK in mice with experimental autoimmune encephalomyelitis.
Fang L, Wang Y, Zheng Q, Yang T, Zhao P, Zhao H, Zhang Q, Zhao Y, Qi F, Li K, Chen Z, Li J, Zhang N, Fan Y, Wang L. Fang L, et al. BMC Complement Altern Med. 2017 Jul 1;17(1):346. doi: 10.1186/s12906-017-1847-4. BMC Complement Altern Med. 2017. PMID: 28668079 Free PMC article. - High-Throughput NanoBiT-Based Screening for Inhibitors of HIV-1 Vpu and Host BST-2 Protein Interaction.
Li B, Dong X, Zhang W, Chen T, Yu B, Zhao W, Yang Y, Wang X, Hu Q, Wang X. Li B, et al. Int J Mol Sci. 2021 Aug 27;22(17):9308. doi: 10.3390/ijms22179308. Int J Mol Sci. 2021. PMID: 34502213 Free PMC article. - Pharmacological Modulators of Small GTPases of Rho Family in Neurodegenerative Diseases.
Guiler W, Koehler A, Boykin C, Lu Q. Guiler W, et al. Front Cell Neurosci. 2021 May 12;15:661612. doi: 10.3389/fncel.2021.661612. eCollection 2021. Front Cell Neurosci. 2021. PMID: 34054432 Free PMC article. - Pharmacological Modulation of Functional Phenotypes of Microglia in Neurodegenerative Diseases.
Song GJ, Suk K. Song GJ, et al. Front Aging Neurosci. 2017 May 15;9:139. doi: 10.3389/fnagi.2017.00139. eCollection 2017. Front Aging Neurosci. 2017. PMID: 28555105 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources